BridgeMD
New treatment option for Frailty
Official title ICOPE Program Feasibility in the Management of Myeloma Patients
ClinicalTrials.gov ID: NCT06247189
What this study is testing
- What it's testing
- This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 70 and older
You may be able to join if
- Male or female aged over 70 years,
- Patient with multiple myeloma
- WHO performance status 0-3,
- Patient eligible for first- or second-line treatment
- Patient willing to participate in ICOPE MONITOR program
You likely can't join if
- Patient in palliative care
- Patient participating in a study evaluating another frailty prevention program
- Patient unable to understand the study
- Patient under court protection, guardianship or curatorship,
- Patient refusal.
See the full eligibility criteria
- Male or female aged over 70 years,
- Patient with multiple myeloma
- WHO performance status 0-3,
- Patient eligible for first- or second-line treatment
- Patient willing to participate in ICOPE MONITOR program
- Patient or caregiver able to use digital tools of ICOPE MONITOR: application or chatbot (computer or tablet or smartphone)
- Patient with a life expectancy of more than 3 months,
- Patient or caregiver able to understand, read and speak French
- Person affiliated or benefiting from a social security.
- Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research)
- Patient in palliative care
- Patient participating in a study evaluating another frailty prevention program
- Patient unable to understand the study
- Patient under court protection, guardianship or curatorship,
- Patient refusal.
The study team makes the final eligibility decision.
Where it's taking place
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 70 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.